Influence of tissue integrity on pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 1, 2011, Pages 186-193

  Anisuzzaman, Abu Syed Md ^a   Nishimune, Atsushi ^a   Yoshiki, Hatsumi ^a   Uwada, Junsuke ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DARIFENACIN; METHOCTRAMINE; METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC TOXIN 3; MUSCARINIC TOXIN 7; OTENZEPAD; PIRENZEPINE; RECOMBINANT RECEPTOR; SOLIFENACIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLADDER MUSCLE; BRAIN CORTEX; BRAIN HOMOGENATE; CONTROLLED STUDY; DISSOCIATION CONSTANT; FEMALE; HIPPOCAMPUS; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR BINDING;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; CRICETULUS; DATA INTERPRETATION, STATISTICAL; KINETICS; MALE; MUSCARINIC ANTAGONISTS; MUSCLE, SMOOTH; N-METHYLSCOPOLAMINE; PHENOTYPE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC;

EID: 80053163064     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.182857     Document Type: Article

References (36)

1. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, De Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, et al. (2006) Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148:565-578. (Pubitemid 43993048)
2. th Edition. Br J Pharmacol 158(Suppl 1):S1-S254.
3. 1 muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors. Eur J Pharmacol 599:146-151.
4. Anisuzzaman AS, Morishima S, Suzuki F, Tanaka T, Yoshiki H, Sathi ZS, Akino H, Yokoyama O, and Muramatsu I (2008b) Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay. J Pharmacol Sci 106:271-279. (Pubitemid 351366347)
5. Baker JG and Hill SJ (2007) Multiple GPCR conformations and signaling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci 28:374-381. (Pubitemid 47087964)
6. Berrie CP, Birdsall NJ, Hulme EC, Keen M, and Stockton JM (1985) Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex. Br J Pharmacol 85:697-703. (Pubitemid 15028812)
7. Bockaert J, Fagni L, Dumuis A, and Marin P (2004) GPCR interacting proteins (GIP). Pharmacol Ther 103:203-221. (Pubitemid 39298464)
8. Boxall DK, Ford AP, Choppin A, Nahorski SR, Challiss RA, and Eglen RM (1998) Characterization of an atypical muscarinic cholinoceptor mediating contraction of the guinea-pig isolated uterus. Br J Pharmacol 124:1615-1622.
9. Bylund DB and Toews ML (1993) Radioligand binding methods: practical guide and tips. Am J Physiol Lung Cell Mol Physiol 265:L421-L429.
10. Caulfield MP and Birdsall NJ (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290. (Pubitemid 28304029)
11. Christopoulos A (2000) Quantification of allosteric interactions at G-protein coupled receptors using radioligand binding assays, in Current Protocols in Pharmacology (Enna SJ, Williams M, Ferkany JW, Kenakin T, Moser P, and Ruggeri B, eds) pp 1.22.1-1.22.40, John Wiley & Sons, Inc., New York.
12. Christopoulos A and Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54:323-374. (Pubitemid 34575719)
13. Dam Trung Tuong M, Garbarg M, and Schwartz JC (1980) Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations. Nature 287:548-551. (Pubitemid 11232855)
14. Delmendo RE, Michel AD, and Whiting RL (1989) Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites. Br J Pharmacol 96:457-464. (Pubitemid 19045123)
15. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, and Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733.
16. Ehlert FJ and Tran LP (1990) Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. J Pharmacol Exp Ther 255: 1148-1157.
17. Ferrari-Dileo G, Waelbroeck M, Mash DC, and Flynn DD (1994) Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Mol Pharmacol 46:1028-1035.
18. Hulme EC, Birdsall NJ, and Buckley NJ (1990) Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673. (Pubitemid 20139559)
19. Kenakin T (2003) Predicting therapeutic value in the lead optimization phase of drug discovery. Nat Rev Drug Discov 2:429-438.
20. Kenakin T, Morgan P, and Lutz M (1995) On the importance of the "antagonist assumption" to how receptors express themselves. Biochem Pharmacol 50:17-26.
21. 5 subtypes of muscarinic receptors in rat heart and brain cortex. Mol Pharmacol 61:1267-1272.
22. Levey AI, Kitt CA, Simonds WF, Price DL, and Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtypespecific antibodies. J Neurosci 11:3218-3226.
23. Morishima S, Suzuki F, Yoshiki H, Md Anisuzzaman AS, Sathi ZS, Tanaka T, and Muramatsu I (2008) Identification of 1L-adrenceptor in rat cerebral cortex and possible relationship between α1L- and α1A-adrenocpetors. Br J Pharmacol 153: 1485-1494. (Pubitemid 351481508)
24. Munns M and Pennefather JN (1998) Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats. Br J Pharmacol 123:1639-1644. (Pubitemid 28182047)
25. Muramatsu I, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, Tanaka T, Rodrigo MC, Myagmar BE, and Simpson PC (2008) Identification of α1Ladrenoceptor in mice and its abolition by α1A-adrenoceptor gene knockout. Br J Pharmacol 155:1224-1234.
26. Muramatsu I, Suzuki F, Nishimune A, Anisuzzaman AS, Yoshiki H, Su TH, Chang CK, and Morishima S (2009) Expression of distinct 1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits. Br J Pharmacol 158:354-360.
27. Muramatsu I, Tanaka T, Suzuki F, Li Z, Hiraizumi-Hiraoka Y, Anisuzzaman AS, Yamamoto H, Horinouchi T, and Morishima S (2005) Quantifying receptor properties: the tissue segment binding method - a powerful tool for the pharmacome analysis of native receptors. J Pharmacol Sci 98:331-339. (Pubitemid 41297006)
28. Nelson CP and Challiss RA (2007) "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73:737-751. (Pubitemid 46237612)
29. 1L-adrenoceptor- expressing cell line. J Pharmacol Sci 113:169-181.
30. Ramachandran R, Mihara K, Mathur M, Rochdi MD, Bouvier M, Defea K, and Hollenberg MD (2009) Agonist-biased signaling via proteinase activated receptor- 2: differential activation of calcium and mitogen-activated protein kinase pathways. Mol Pharmacol 76:791-801.
31. Sathi ZS, Anisuzzaman AS, Morishima S, Suzuki F, Tanaka T, Yoshiki H, and Muramatsu I (2008) Different affinities of native α1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations. Eur J Pharmacol 584:222-228.
32. Su TH, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, Tanaka T, Cheng JT, and Muramatsu I (2008) Native profiles of α1A-adrenoceptor phenotypes in rabbit prostate. Br J Pharmacol 155:906-912.
33. Van Koppen CJ and Kaiser B (2003) Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 98:197-220. (Pubitemid 36513775)
34. 4) in rat forebrain. Mol Pharmacol 38:267-273.
35. Wess J, Eglen RM, and Gautam D (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721-733. (Pubitemid 47342315)
36. Yoshiki H, Nishimune A, Suzuki F, Morishima S, Ikeda T, Sasaki M, Audigane LM, Gauthier C, and Muramatsu I (2009) Evaluation of 1L-adrenoceptors in rabbit heart by tissue segment binding assay. J Pharmacol Sci 110:389-396.